feed,title,long_url,short_url
Benzinga,Atossa Therapeutics' COVID-19 Nasal Spray Safe In Early-Stage Study,https://benzinga.com/general/biotech/21/02/19853745/atossa-therapeutics-covid-19-nasal-spray-safe-in-early-stage-study,
Benzinga,Exelixis' Cabozantinib Gets Breakthrough Therapy Status In Differentiated Thyroid Cancer,https://benzinga.com/general/biotech/21/02/19852966/exelixis-cabozantinib-gets-breakthrough-therapy-status-in-differentiated-thyroid-cancer,
